VivoSeq
Other

Absorption

0

Pipeline Programs↗

2

Active Trials↗

82

Companies Involved↗

Absorption is an early-stage landscape with 0 programs across 82 companies. The most active players are Pfizer, AstraZeneca, GSK.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalOrion Corporation, Orion Pharma logo

Orion Corporation, Orion Pharma

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

284

clinical trials

Completed254 · 89%
Terminated11 · 4%
Unknown status10 · 4%
Withdrawn5 · 2%
Suspended2 · 1%
Not yet recruiting1 · 0%
Other1 · 0%

Clinical Trials

Trial Activity

284 trials

A Randomized, Double-blind Placebo-controlled Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources in Natural Triglyceride Form to One Fish Source in Re-esterified Triglyceride Form (GOBO 2 Study)
Active, not recruiting·RRDC Clinical Pty Ltd·Phase 3·NCT07241377·120 enrolled
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
Not yet recruiting·AAspargo Labs, Inc·Phase 2·NCT07290400·36 enrolled
A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589
Completed·Novartis logoNovartis·Phase 1·NCT00472368·4 enrolled
To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305
Completed·AstraZeneca logoAstraZeneca·Phase 1·NCT00689247·10 enrolled
TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
Completed·MMylan Inc.·Phase 1·NCT02772159·9 enrolled
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
Completed·AAsana BioSciences·Phase 1·NCT03641573·8 enrolled
A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)
Completed·LLeonaBio·Phase 1·NCT05511558·8 enrolled
Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants
Completed·Bayer logoBayer·Phase 1·NCT04771390·52 enrolled
Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
Completed·ZZydus Therapeutics Inc.·Phase 1·NCT04112446·8 enrolled
A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200
Completed·PPyramid Biosciences·Phase 1·NCT05160389·16 enrolled
Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects
Completed·EEmalex Biosciences Inc.·Phase 1·NCT04881955·8 enrolled
Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025
Completed·KKadmon Corporation, LLC·Phase 1·NCT03907540·5 enrolled
A Study to Evaluate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813
Completed·Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logoJohnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 1·NCT01932320·36 enrolled
Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration
Completed·Eli Lilly logoEli Lilly·Phase 1·NCT03040362·8 enrolled
A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects
Completed·Amgen logoAmgen·Phase 1·NCT05578859·8 enrolled
Page 1 of 19

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)